Hakan Çiftçi | Neuropharmacology | Best Researcher Award

Posted on by Neuroscientists

Assoc. Prof. Dr. Hakan Çiftçi | Neuropharmacology | Best Researcher Award

Assoc. Prof. Dr. Hakan Çiftçi,  Afyon Kocatepe University, Turkey.

Assoc. Prof. Dr. Hakan Çiftçi is a distinguished academic and researcher at Afyon Kocatepe University with a strong foundation in Mining Engineering. Transitioning from field engineering to academia, he has carved a niche in mineral processing, materials science, and nanotechnology. His research focuses on innovative drug delivery systems, advanced clay-based composites, and environmental remediation techniques. With multiple high-impact publications, two patents, and active involvement in industry-driven projects, Dr. Çiftçi exemplifies interdisciplinary excellence. His work not only enhances scientific understanding but also provides practical solutions in medicine, mining, and environmental engineering.

Profile

Google Scholar

Orcid

 

🎓 Early Academic Pursuits

Hakan Çiftçi embarked on his academic journey with a bachelor’s degree in Mining Engineering from the prestigious Istanbul Technical University, graduating in 2011. His early exposure to the fundamentals of earth sciences and engineering instilled a strong foundation in mineralogy, thermodynamics, and process design. Shortly after completing his undergraduate studies, he gained firsthand industrial experience as a mining engineer. However, his passion for research and innovation soon guided him toward academia, where he would find his true calling.

🧪 Professional Endeavors in Mineral Processing

Transitioning from industry to academia, Dr. Çiftçi began his career as a research academician at Afyon Kocatepe University in the Department of Mineral Processing and Enrichment. Over the years, he steadily climbed the academic ranks to become an Associate Professor. His professional work is characterized by a multidisciplinary approach, combining traditional mineral processing techniques with modern material science, polymer chemistry, and nanotechnology, positioning him as a key contributor in applied and experimental mineral-based research.

🧬 Research Focus and Scientific Contributions

Assoc. Prof. Dr. Çiftçi’s research spans a diverse yet interconnected set of fields. He is deeply invested in the synthesis and characterization of advanced nanocomposites, particularly those based on montmorillonite and magnetite, with applications in drug delivery systems and environmental remediation. His work includes developing smart drug release systems, bone cement with antibiotic properties, and advanced bentonite-based materials for radiation shielding. His investigations also extend to dry enrichment techniques, microwave-assisted mineral dissolution, and surface property analysis of industrial materials. With over a dozen major research projects completed or ongoing, his contributions significantly enhance both theoretical understanding and industrial application.

📚 Publications, Patents, and Scholarly Output

A prolific scholar, Dr. Çiftçi has published extensively and authored a book titled “An Introduction to Montmorillonite Purification” (ISBN: 978-1-83968-603-0), which underscores his expertise in clay minerals and their purification. He holds two patents: one on a novel drug delivery system for capsaicin and another on the dry enrichment method for bentonites, reflecting his innovation-driven mindset. His citation metrics—h-index of 8 and i10-index of 7—testify to the growing academic impact of his work.

🏭 Industry Collaboration and Practical Impact

Beyond academic settings, Dr. Çiftçi collaborates with various industrial partners on impactful projects. These include analyzing morphine and codeine phosphate materials, assessing coastal sand health implications, and developing advanced enrichment devices like dynamic separators and aero cyclones. His research has immediate applicability in health, mining, and materials industries, bridging the gap between laboratory-scale research and full-scale industrial implementation.

🏅 Accolades, Recognition, and Influence

Dr. Çiftçi’s work has garnered recognition in both academic and industrial communities. His involvement in cutting-edge materials research and the integration of nanotechnology into mineral applications position him as a rising thought leader in his field. His innovations in drug delivery and sustainable mineral processing are paving the way for future advancements, particularly in therapeutic materials and environmentally conscious engineering solutions.

🔮 Legacy and Future Contributions

Looking forward, Assoc. Prof. Dr. Hakan Çiftçi aims to further advance the fusion of nanotechnology with mineral processing, contributing to smarter, safer, and more sustainable material systems. His commitment to mentoring young scientists, coupled with his broad interdisciplinary expertise, ensures a lasting legacy in academia and industry alike. As he continues to push the boundaries of traditional mineral engineering, his future contributions are expected to leave a significant imprint on the scientific community and human health.

Publication

  • Removal of methylene blue from water by ultrasound-assisted adsorption using low-cost bentonites
    H Çiftçi — 2022

 

  • Synthesis, Characterization and Cr (VI) Adsorption Properties of Modified Magnetite Nanoparticles
    H Çiftçi, B Ersoy, A Evcin — 2017

 

  • Development and evaluation of mesoporous montmorillonite/magnetite nanocomposites loaded with 5-Fluorouracil
    H Çiftçi, MD Arpa, İM Gülaçar, L Özcan, B Ersoy — 2020

 

  • Purification of Turkish Bentonites and Investigation of the Contact Angle, Surface Free Energy and Zeta Potential Profiles of Organo-Bentonites as a Function of CTAB Concentration
    H Çiftçi, B Ersoy, A Evcin — 2020

 

  • An Introduction to Montmorillonite Purification
    H Ciftci — 2021

 

  • Novel functional copolymers based on glycidyl methacrylate: Synthesis, characterization, and polymerization kinetics
    I Erol, DN Devrim, H Ciftci, B Ersoy, IH Cigerci — 2017

 

  • Utilization of Marble and Boron Waste in Brick Products
    A Evcin, B Ersoy, H Çiftçi — 2019

 

  • Pillared magnetite/clay structures as a function of Ctab and Teos concentrations
    H Çiftçi, B Ersoy, A Evcin — 2020

 

  • Afyonkarahisar bölgesi mermer parça atıklarının beton agregası olarak değerlendirilebilirliğinin araştırılması
    Z Arsoy, H Çiftçi, B Ersoy, T Uygunoğlu, B Arslan — 2019

 

  • Coal recovery from coal washing plant tailings with Knelson concentrator
    S Özgen, Z Arsoy, B Ersoy, H Çiftçi — 2019

 

✅ Conclusion

Dr. Hakan Çiftçi stands out as a dynamic and forward-thinking researcher whose multidisciplinary approach addresses real-world challenges through scientific innovation. His contributions have bridged the gap between mineral engineering and biomedical applications, positioning him as a valuable asset to the global research community. With ongoing research, patented technologies, and a commitment to future advancements, Dr. Çiftçi is poised to make lasting impacts in both academia and industry.

Yanjie Wang | Neuropharmacology | Best Researcher Award

Posted on by Neuroscientists

Mr. Yanjie Wang | Neuropharmacology | Best Researcher Award

Mr. Yanjie Wang, Shanxi Medical University,  China.

Yanjie Wang is a dedicated Ph.D. candidate in Otorhinolaryngology at Shanxi Medical University, with a strong foundation in clinical medicine and academic research. After earning his M.S. in 2020, he served as a Lecturer and Physician at the Second Hospital of Shanxi Medical University. Since 2022, his doctoral work under Prof. Changqing Zhao has centered on the neuroimmune mechanisms of airway hyperresponsiveness, especially the TRPV1 pathway’s role in allergic rhinitis. With active involvement in multiple national and provincial research projects, over ten scientific publications, and conference presentations, Mr. Wang has made significant strides in linking basic science with clinical relevance. His research highlights the interplay between peripheral allergens and central neural pathways and suggests novel therapeutic avenues for allergic airway diseases.

Profile

Scopus

🎓 Early Academic Pursuits

Yanjie Wang embarked on his academic journey in medical science at Shanxi Medical University, where he demonstrated a strong commitment to otorhinolaryngological studies early on. He earned his Master of Science degree in 2020, laying a firm foundation in clinical and research methodologies. His academic curiosity and rigor soon led him to pursue a Ph.D. in Otorhinolaryngology under the mentorship of Professor Changqing Zhao, where he delved deeply into the intricacies of airway neuroimmune mechanisms. This academic progression marked the beginning of a promising research trajectory focusing on allergic airway disorders.

🩺 Professional Endeavors

Following his M.S. degree, Mr. Wang began his clinical career as a Lecturer and Physician at the Second Hospital of Shanxi Medical University. Balancing patient care with academic responsibilities, he gained valuable experience in both educational instruction and clinical practice. In 2022, he transitioned into full-time doctoral research, dedicating his efforts to understanding the interplay between peripheral inflammation and central nervous regulation in respiratory conditions. His dual background in clinical service and research gives him a unique perspective in translational medicine.

🔬 Contributions and Research Focus

Mr. Wang’s research centers on the neuroimmune interactions involved in airway hyperresponsiveness, particularly allergic rhinitis (AR). His investigations have highlighted the upregulation of TRPV1 channels in AR patients and their correlation with symptom severity, including sneezing and nasal itching. Furthermore, he elucidated the TRPV1-NF-κB pathway’s role in allergen-induced IL-33 secretion in human nasal epithelial cells (hNECs), identifying TRPV1 as a critical modulator of nasal immune responses. His findings further demonstrate that TRPV1 inhibition significantly reduces OVA-induced innate nasal epithelial activation, offering potential therapeutic implications.

🧪 Research Projects and Innovation

Through his active involvement in cutting-edge research, Mr. Wang has participated in three projects funded by the National Natural Science Foundation and led two significant provincial grants—namely the Basic Research Project of Shanxi Province (No. 202203021222390) and the Youth Project of the Second Hospital of Shanxi Medical University (No. 202302-9). These projects have advanced understanding of epithelial immune responses and neuroimmune regulation in allergic diseases. His ability to merge molecular biology, immunology, and clinical perspectives has positioned him as a rising voice in the field of upper airway disease research.

🏅 Accolades and Recognition

Yanjie Wang’s dedication to research and clinical advancement has resulted in more than ten peer-reviewed publications in SCI and other core journals. His work has not only been published but also presented at multiple national academic conferences, earning respect from peers and experts alike. His increasing citation index—marked by the notable 2025 publication on TRPV1 inhibition in nasal inflammation—reflects the relevance and growing impact of his work in both national and international scientific communities.

🌍 Impact and Influence

Mr. Wang’s studies contribute meaningfully to the understanding of allergic airway disease mechanisms, especially regarding epithelial-neural-immune crosstalk. His research outcomes have the potential to reshape therapeutic approaches for allergic rhinitis by targeting neuroimmune pathways rather than relying solely on antihistamines and corticosteroids. Through mentorship and interdisciplinary collaboration, he is fostering a network of emerging scholars and promoting evidence-based advancements in respiratory immunology.

🚀 Legacy and Future Contributions

Looking ahead, Yanjie Wang is poised to become a leading expert in airway neuroimmunology. His future ambitions include translating his basic research into clinical innovations that improve patient outcomes and developing novel therapeutic strategies targeting TRP channels in allergic diseases. His commitment to merging scientific exploration with clinical relevance ensures that his work will leave a lasting legacy in otorhinolaryngological research and patient care.

Publication

Title: Inhibition of TRPV1 attenuates innate nasal epithelial responses via NF-κB signaling pathway in allergic rhinitis
Authors: Wang, Yanjie; Qi, Xueping; Li, Hanxiong; Cheng, Fengli; Zhao, Changqing
Year: 2025

 

✅ Conclusion

Yanjie Wang stands out as a promising scholar whose work bridges clinical practice and experimental science. His research into TRPV1-mediated neuroimmune responses is not only timely but potentially transformative in treating allergic airway conditions. As he continues to deepen his investigations and expand his academic impact, his contributions are expected to drive innovation in the diagnosis, management, and therapy of upper airway disorders. His career trajectory signals a future leader in respiratory immunology and translational otorhinolaryngological research.